Skip to main content
FinSpry Logo
FinSpry
MDXG logo
MDXG
(NASDAQ)
MiMedx Group, Inc.
$3.92-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

MiMedx Group (MDXG) Stock Price & Financial Analysis

MiMedx Group Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.81 - $3.97
52-Week High$7.99
52-Week Low$3.77
Open$3.97
Volume1.68M
Average Volume (3M)1.68M
Market Cap586.92M
Shares Outstanding149.72M
P/E Ratio (TTM)12.17
Forward P/E10.63
Price to Sales (P/S)1.41
Price to Book (P/B)2.31
EV/EBITDA5.55
Revenue (TTM)418.63M
Net Income (TTM)48.58M
Free Cash Flow (TTM)69.11M
EPS (TTM)$0.32
Profit Margin11.60%
Operating Margin15.26%
Return on Equity (ROE)18.94%
Debt to Equity0.09
50-Day MA$4.78
200-Day MA$6.32
52-Week Change-47.33%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About MiMedx Group

What is the current stock price for MDXG?

As of the latest trading session, MDXG stock trades at $3.92. The 52-week range is $3.77–$7.99, with a day range of $3.81–$3.96.

What is the P/E ratio for MDXG?

MiMedx Group's trailing P/E ratio is 12.2, meaning investors pay $12.2 for every $1 of annual earnings. The forward P/E is 10.6, reflecting analyst expectations for future earnings. MiMedx Group operates in the Healthcare sector.

Does MDXG pay dividends?

MiMedx Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MDXG?

Based on 3 analysts, the consensus for MDXG is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MDXG?

MiMedx Group's market capitalization is $586.9M, classifying it as a small-cap company. MiMedx Group operates in the Healthcare sector within the Biotechnology industry.